Isolated Hepatic Perfusion for the Treatment of Liver Tumors: Sunset or Sunrise?

Cornelis Verhoef, Johannes H.W. de Wilt, Timo L.M. ten Hagen, Alexander M.M. Eggermont

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenpeer review

1 Citaat (Scopus)

Samenvatting

Experience with isolated hepatic perfusion (IHP) is limited to a few centers in the world because of the technical difficulties, surgery-related morbidity, and unproved efficacy in randomized trials. Experimental animal IHP models have led to exploring new ways of improving efficacy, reducing technical difficulties, and minimizing regional and systemic toxicity. Future research should be directed to the identification of suitable biologic or chemotherapeutic agents, defining clinical indications, and development of technical modifications to make it more generally applicable and even repeatable.

Originele taal-2Engels
Pagina's (van-tot)877-894
Aantal pagina's18
TijdschriftSurgical Oncology Clinics of North America
Volume17
Nummer van het tijdschrift4
DOI's
StatusGepubliceerd - okt. 2008
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Isolated Hepatic Perfusion for the Treatment of Liver Tumors: Sunset or Sunrise?'. Samen vormen ze een unieke vingerafdruk.

Citeer dit